 |
|
|
|
|
 |
 |
|
Surrogate endpoint evaluation based on historical trials
|
|
|
|
|
|
| Organization: | National Cancer Institute |
|
|
|
|
|
|
This software fits a zero-intercept random effects linear model to data on surrogate and true endpoints in previous trials.
Reference: Baker SG. Five criteria for using a surrogate endpoint to predict treatment effect based on data from multiple previous trials. Statistics in Medicine 2018 37(4):507-518.
|
|
|
|
|
|
|
|
|
|
|
|
surrogate endpoints, criteria
|
|
|
|
|
|
| Surrogate endpoint evaluation based on historical trials.zip (30.5 KB) - ZIP archive |
|
|
For the newest resources, visit Wolfram Repositories and Archives »
